![1]()
News
Apixaban noninferior to low-molecular-weight heparin in cancer-associated VTE
December 6, 2021
Is oral apixaban as safe and effective as subcutaneous dalteparin in treating venous thromboembolism (VTE) in patients with underlying cancer?
News
Rituximab likely raises risk of hospital death in COVID-19 patients
December 2, 2021
In a retrospective study of hospitalized COVID-19 patients, “only 1 of 303 drugs examined, rituximab, was associated with an increased risk of in-hospital death ... both when used for rheumatologic as well as for cancer therapy.”
![1]()
News
Tranexamic acid does not reduce risk of death in GI bleed
December 2, 2021
In patients with GI bleeding, does high-dose tranexamic acid (TXA) reduce the risk of death?
![1]()
News
Oakland score identifies patients with lower GI bleed at low risk for adverse events
November 23, 2021
Is the Oakland score a valid tool to assess the risk of adverse outcomes in adult patients with acute lower GI bleed (LGIB)?
![1]()
News
Timing of endoscopy for acute upper GI bleeding
November 18, 2021
In high-risk patients hospitalized with upper GI bleeding, is earlier endoscopy beneficial?
![1]()
News
Ticagrelor reversal agent achieves quick hemostasis: REVERSE-IT
November 17, 2021
The monoclonal antibody bentracimab, which can rapidly reverse ticagrelor, was found effective and safe in an FDA-requested interim analysis of a phase 3 trial.
News
Severe COVID two times higher for cancer patients
November 8, 2021
Cancer patients are at high risk of developing COVID-19 with severe outcomes, but the magnitude of the risk hasn’t been documented on a wide scale until now.
![1]()
News
Autopsy findings reveal venous thromboembolism in patients with COVID-19
October 12, 2021
What pathologic features contribute to the cause of death in COVID-19?
News
Rivaroxaban’s single daily dose may lead to higher bleeding risk than other DOACs
October 11, 2021
Corroborating previous studies, Iceland researchers report that rivaroxaban poses the highest risk of GI bleeding, compared with other DOACs.
News
EU finds J&J COVID shot possibly linked to another rare clotting condition
October 4, 2021
EMA said the new, possibly life-threatening VTE condition to be included on the J&J product label was separate from TTS.
